# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
BTIG analyst Ryan Zimmerman upgrades Staar Surgical (NASDAQ:STAA) from Neutral to Buy and announces $46 price target.
Needham analyst David Saxon reiterates Staar Surgical (NASDAQ:STAA) with a Hold.
Canaccord Genuity analyst Jon Young maintains Staar Surgical (NASDAQ:STAA) with a Hold and lowers the price target from $46 ...
Piper Sandler analyst Matt O'Brien maintains Staar Surgical (NASDAQ:STAA) with a Neutral and raises the price target fro...
Mizuho analyst Anthony Petrone maintains Staar Surgical (NASDAQ:STAA) with a Buy and raises the price target from $53 to $55.
Agreement is Largest Commitment to EVO ICL™ in the U.S.STAAR Surgical Company (NASDAQ:STAA), a leading developer, manufacturer ...